Infosys reported Q1 FY27 consolidated revenue of ₹48,211 crore, representing 14.0% YoY growth (2.4% constant currency growth), with net profit rising 12.3% to ₹7,775 crore. The company maintained a resilient operating margin of 21.1%, showing 30 bps YoY improvement.
Key Financial Highlights:
- Revenue growth was led by North America (56.4% of revenue, ₹27,167 crore) and Europe (32.1%, ₹15,499 crore)
- Life Sciences segment showed strongest growth at 26.3% YoY, while Retail declined 1.5%
- Large deal wins totaled $3.6 billion with 61% net new content
- Free cash flow was strong at ₹9,051 crore (116.4% of net profit conversion)
- AI contributed 8.2% of total revenue
Corporate Actions & Leadership:
The Board appointed Ashiss Kumar Dash as CEO Designate effective immediately, with planned succession to CEO/MD on April 1, 2027 for a 5-year term. The company declared a final dividend of ₹25 per share for FY26, resulting in a cash outflow of ₹10,123 crore.
Strategic Initiatives:
Infosys completed two acquisitions through Infosys Nova Holdings LLC: Stratus Global LLC (₹697 crore) to strengthen insurance technology capabilities, and Optimum Achieve Holdings Inc. (₹3,470 crore) to expand healthcare digital transformation services.
Guidance Revision:
The company revised its FY27 revenue guidance downward to 1.5%-3.0% constant currency growth (from previous guidance) while maintaining operating margin guidance of 20%-22%.
Regulatory & Compliance:
Deloitte Haskins & Sells LLP provided clean audit opinions for both standalone and consolidated financial statements. The U.S. Department of Justice investigation regarding H-1B visa classification continues, with the company engaged in discussions with DOJ.